We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iq-ai Limited | LSE:IQAI | London | Ordinary Share | JE00BD4H0R42 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 1.50 | 1.70 | 1.60 | 1.55 | 1.60 | 326,452 | 14:24:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Florists | 609k | -624k | -0.0028 | -5.71 | 3.55M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2023 08:53 | Well Clocky lad, you can safely forget your 7p target price. It's half of that to sell very few shares now.Something simply not right with this. | festario | |
05/12/2023 14:56 | This was the RNS I was hoping for, but I can't now sell a single share at 3.7pIt's a shame, but no one believes anything from companies involving Trevor any longer. If this was a recently launched tech company, with the people who run IB at the helm of it, this would be 300p now. As it is, we'll be lucky to close level. | festario | |
05/12/2023 14:15 | Yet another positive sounding Trevor style RNS, with little impact.Max to sell 50k shares at a paltry 3.7p Ho hum. | festario | |
05/12/2023 12:28 | LSE order book stocks to resume with an uncrossing at 12:40 | spurs90 | |
05/12/2023 12:02 | Thanks for that | howdlep | |
05/12/2023 11:37 | Think it’s because of another London Stock Exchange issue | spurs90 | |
05/12/2023 11:31 | Yes excellent confirmatory news. What is interesting is that we are currently NT to buy and sell. Edit: that is with HL | howdlep | |
05/12/2023 11:30 | Good news markets/TB link just unwilling to let this go up | joeblogg2 | |
05/12/2023 11:03 | That's the news we have been waiting for target up to 7p now. | clocktower | |
23/11/2023 15:18 | Just waiting for the next news which hopefully will drive it up to my target. | clocktower | |
20/11/2023 14:35 | Looks like he's selling them already | festario | |
20/11/2023 13:48 | Is that RNS just confirmation of Trevor's new holding, after he converted his loan at 1.5p | festario | |
16/11/2023 13:54 | but no one is selling either, as everyone knows multiple news is coming. | howdlep | |
16/11/2023 13:10 | Another of those 'regular' updates please Trev, and make it a good one. Share price is flagging, and no new interest in terms of investors or Twitter followers. | festario | |
14/11/2023 07:35 | Yes on the one hand, albeit he can do that anytime. On the other hand, potential investors should beware a huge gap up RNS. It could drop any day. | howdlep | |
14/11/2023 07:25 | Exciting times ahead but it all depends on TB choosing the time that he wants to finish converting. | clocktower | |
14/11/2023 07:13 | Here is the link to the clinical trial update if you haven't already seen it:- | howdlep | |
14/11/2023 00:14 | Please present them to shareholders beforehand! | festario | |
13/11/2023 23:13 | Safe travels to @JenConnellyMD as she travels to #SNO2023 where she will present preliminary results of @IQAI_IB's sponsored phase 1 clinical trial. | howdlep | |
12/11/2023 20:31 | Any idea how much that's worth to IB ? | festario | |
12/11/2023 19:06 | Congratulations to Dr. Mona Al-Gizawiy, PhD from the Schmainda Lab @MedicalCollege for being awarded not 1, but 2, @ahwendowment grants. The grants will fund the continued development and application of GaM, the oral agent under study in @IQAI_IB 's phase 1 clinical trial. | spurs90 | |
12/11/2023 08:14 | There are more CLN’s. Last results show £217,784. When company needs dough TB sells some stock, converts CLN’s to get back to 29.9%. I bet more CLN’s have been issued to TB in last few weeks. | rock star |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions